BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 9476120)

  • 1. Complement receptor 1/CD35 is a receptor for mannan-binding lectin.
    Ghiran I; Barbashov SF; Klickstein LB; Tas SW; Jensenius JC; Nicholson-Weller A
    J Exp Med; 2000 Dec; 192(12):1797-808. PubMed ID: 11120776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxicity of an algal mucopolysaccharide for Escherichia coli and Neisseria meningitidis strains.
    Criado MT; Ferreirós CM
    Rev Esp Fisiol; 1984 Jun; 40(2):227-30. PubMed ID: 6237397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of DNA-protein complexes by nanoparticle tracking analysis and their association with systemic lupus erythematosus.
    Juul-Madsen K; Troldborg A; Wittenborn TR; Axelsen MG; Zhao H; Klausen LH; Luecke S; Paludan SR; Stengaard-Pedersen K; Dong M; Møller HJ; Thiel S; Jensen H; Schuck P; Sutherland DS; Degn SE; Vorup-Jensen T
    Proc Natl Acad Sci U S A; 2021 Jul; 118(30):. PubMed ID: 34301873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collectins: Innate Immune Pattern Recognition Molecules.
    Murugaiah V; Tsolaki AG; Kishore U
    Adv Exp Med Biol; 2020; 1204():75-127. PubMed ID: 32152944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms and regulation of the gene-expression response to sepsis.
    Cornell TT; Wynn J; Shanley TP; Wheeler DS; Wong HR
    Pediatrics; 2010 Jun; 125(6):1248-58. PubMed ID: 20478944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical roles of complement and antibodies in host defense mechanisms against Neisseria meningitidis as revealed by human complement genetic deficiencies.
    Hellerud BC; Aase A; Herstad TK; Naess LM; Kristiansen LH; Trøseid AM; Harboe M; Lappegård KT; Brandtzaeg P; Høiby EA; Mollnes TE
    Infect Immun; 2010 Feb; 78(2):802-9. PubMed ID: 19933829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional opsonic activity of human serum antibodies to inner core lipopolysaccharide (galE) of serogroup B meningococci measured by flow cytometry.
    Plested JS; Ferry BL; Coull PA; Makepeace K; Lehmann AK; MacKinnon FG; Griffiths HG; Herbert MA; Richards JC; Moxon ER
    Infect Immun; 2001 May; 69(5):3203-13. PubMed ID: 11292742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination responses to capsular polysaccharides of Neisseria meningitidis and Haemophilus influenzae type b in two C2-deficient sisters: alternative pathway-mediated bacterial killing and evidence for a novel type of blocking IgG.
    Selander B; Käyhty H; Wedege E; Holmström E; Truedsson L; Söderström C; Sjöholm AG
    J Clin Immunol; 2000 Mar; 20(2):138-49. PubMed ID: 10821465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement deficiency states and meningococcal disease.
    Figueroa J; Andreoni J; Densen P
    Immunol Res; 1993; 12(3):295-311. PubMed ID: 8288947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mannose-binding lectin: targeting the microbial world for complement attack and opsonophagocytosis.
    Jack DL; Klein NJ; Turner MW
    Immunol Rev; 2001 Apr; 180():86-99. PubMed ID: 11414367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of mannan-binding lectin on opsonophagocytosis of Neisseria meningitidis.
    Drogari-Apiranthitou M; Fijen CA; Thiel S; Platonov A; Jensen L; Dankert J; Kuijper EJ
    Immunopharmacology; 1997 Dec; 38(1-2):93-9. PubMed ID: 9476120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-dependent killing of meningococci by human neutrophils in serum of late complement component-deficient patients.
    Platonov AE; Vershinina IV; Käyhty H; Fijen CA; Würzner R; Kuijper EJ
    Int Arch Allergy Immunol; 2003 Apr; 130(4):314-21. PubMed ID: 12740533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phagocytic killing and antibody response during the first year after tetravalent meningococcal vaccine in complement-deficient and in normal individuals.
    Schlesinger M; Kayhty H; Levy R; Bibi C; Meydan N; Levy J
    J Clin Immunol; 2000 Jan; 20(1):46-53. PubMed ID: 10798607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against meningococcal serogroup ACYW disease in complement-deficient individuals vaccinated with the tetravalent meningococcal capsular polysaccharide vaccine.
    Fijen CA; Kuijper EJ; Drogari-Apiranthitou M; Van Leeuwen Y; Daha MR; Dankert J
    Clin Exp Immunol; 1998 Dec; 114(3):362-9. PubMed ID: 9844044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mannose-binding lectin accelerates complement activation and increases serum killing of Neisseria meningitidis serogroup C.
    Jack DL; Jarvis GA; Booth CL; Turner MW; Klein NJ
    J Infect Dis; 2001 Oct; 184(7):836-45. PubMed ID: 11509995
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.